List of Excipients in API ALISKIREN HEMIFUMARATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ALISKIREN HEMIFUMARATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | TEKTURNA | aliskiren hemifumarate | 50090-2985 | CELLULOSE, MICROCRYSTALLINE | |
| A-S Medication Solutions | TEKTURNA | aliskiren hemifumarate | 50090-2985 | CROSPOVIDONE | |
| A-S Medication Solutions | TEKTURNA | aliskiren hemifumarate | 50090-2985 | FERRIC OXIDE RED | |
| A-S Medication Solutions | TEKTURNA | aliskiren hemifumarate | 50090-2985 | FERROSOFERRIC OXIDE | |
| A-S Medication Solutions | TEKTURNA | aliskiren hemifumarate | 50090-2985 | HYPROMELLOSE | |
| A-S Medication Solutions | TEKTURNA | aliskiren hemifumarate | 50090-2985 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ALISKIREN HEMIFUMARATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ALISKIREN HEMIFUMARATE drug variants containing CELLULOSE, MICROCRYSTALLINE
ALISKIREN HEMIFUMARATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
ALISKIREN HEMIFUMARATE drug variants containing CROSPOVIDONE
ALISKIREN HEMIFUMARATE drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
ALISKIREN HEMIFUMARATE drug variants containing FERRIC OXIDE RED
ALISKIREN HEMIFUMARATE drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
ALISKIREN HEMIFUMARATE drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | aliskiren hemifumarate and hydrochlorothiazide | 54868-6041 |
| >Company | >Ingredient | >NDC |
ALISKIREN HEMIFUMARATE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
ALISKIREN HEMIFUMARATE drug variants containing FERROSOFERRIC OXIDE
ALISKIREN HEMIFUMARATE drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Noden Pharma USA Inc | aliskiren hemifumarate and hydrochlorothiazide | 70839-112 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
ALISKIREN HEMIFUMARATE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | aliskiren hemifumarate | 50090-2985 |
| >Company | >Ingredient | >NDC |
ALISKIREN HEMIFUMARATE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
ALISKIREN HEMIFUMARATE drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | aliskiren hemifumarate and hydrochlorothiazide | 54868-6041 |
| >Company | >Ingredient | >NDC |
ALISKIREN HEMIFUMARATE drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSES
ALISKIREN HEMIFUMARATE drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | aliskiren hemifumarate | 54868-5772 |
| Prasco Laboratories | aliskiren hemifumarate | 66993-141 |
| LXO US Inc | aliskiren hemifumarate | 70839-150 |
| Noden Pharma USA Inc | aliskiren hemifumarate and hydrochlorothiazide | 70839-112 |
| >Company | >Ingredient | >NDC |
ALISKIREN HEMIFUMARATE drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | aliskiren hemifumarate | 50090-2985 |
| Physicians Total Care Inc | aliskiren hemifumarate and hydrochlorothiazide | 54868-6041 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
ALISKIREN HEMIFUMARATE drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | aliskiren hemifumarate and hydrochlorothiazide | 54868-6041 |
| Noden Pharma USA Inc | aliskiren hemifumarate and hydrochlorothiazide | 70839-112 |
| >Company | >Ingredient | >NDC |
ALISKIREN HEMIFUMARATE drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | aliskiren hemifumarate | 50090-2985 |
| Physicians Total Care Inc | aliskiren hemifumarate | 54868-5772 |
| Prasco Laboratories | aliskiren hemifumarate | 66993-141 |
| LXO US Inc | aliskiren hemifumarate | 70839-150 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ALISKIREN HEMIFUMARATE drug variants containing MAGNESIUM STEARATE
ALISKIREN HEMIFUMARATE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
ALISKIREN HEMIFUMARATE drug variants containing POLYETHYLENE GLYCOL
ALISKIREN HEMIFUMARATE drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
ALISKIREN HEMIFUMARATE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | aliskiren hemifumarate and hydrochlorothiazide | 54868-6041 |
| Noden Pharma USA Inc | aliskiren hemifumarate and hydrochlorothiazide | 70839-112 |
| >Company | >Ingredient | >NDC |
ALISKIREN HEMIFUMARATE drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | aliskiren hemifumarate | 50090-2985 |
| Physicians Total Care Inc | aliskiren hemifumarate | 54868-5772 |
| Prasco Laboratories | aliskiren hemifumarate | 66993-141 |
| LXO US Inc | aliskiren hemifumarate | 70839-150 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ALISKIREN HEMIFUMARATE drug variants containing SILICON DIOXIDE
ALISKIREN HEMIFUMARATE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | aliskiren hemifumarate | 54868-5772 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE, COLLOIDAL
ALISKIREN HEMIFUMARATE drug variants containing SILICON DIOXIDE, COLLOIDAL
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | aliskiren hemifumarate | 54868-5772 |
| >Company | >Ingredient | >NDC |
ALISKIREN HEMIFUMARATE drug variants not containing SILICON DIOXIDE, COLLOIDAL
Excipient focus: STARCH, WHEAT
ALISKIREN HEMIFUMARATE drug variants containing STARCH, WHEAT
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | aliskiren hemifumarate and hydrochlorothiazide | 54868-6041 |
| Noden Pharma USA Inc | aliskiren hemifumarate and hydrochlorothiazide | 70839-112 |
| >Company | >Ingredient | >NDC |
ALISKIREN HEMIFUMARATE drug variants not containing STARCH, WHEAT
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | aliskiren hemifumarate | 50090-2985 |
| Physicians Total Care Inc | aliskiren hemifumarate | 54868-5772 |
| Prasco Laboratories | aliskiren hemifumarate | 66993-141 |
| LXO US Inc | aliskiren hemifumarate | 70839-150 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
ALISKIREN HEMIFUMARATE drug variants containing TALC
ALISKIREN HEMIFUMARATE drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ALISKIREN HEMIFUMARATE drug variants containing TITANIUM DIOXIDE
ALISKIREN HEMIFUMARATE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
